Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   3:59:54 PM EDT
2.80
+0.22 (+8.33%)
Other Pre-Announcement

Amneal Reports Second Quarter 2022 Financial Results

Published: 08/05/2022 11:44 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Reports Second Quarter 2022 Financial Results.
Q2 2022 Net Revenue of $559 Million; GAAP Net Loss of $121 Million; Diluted Loss per Share of $0.80.
Qtrly Adjusted Diluted EPS of $0.19.
Is Updating Its Full Year 2022 Guidance.
Sees 2022 Adjusted Diluted EPS $0.65 - $0.70.
Q2 Earnings per Share View $0.19, Revenue View $536.3 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $0.80 -- Refinitiv Ibes Data (analyst estimates).